Abstract
Parkinson’s disease (PD) is a neurodegenerative disease. L-dopa-induced dyskinesia (LID) is one of the main types of drug-induced dyskinesia, occurring in patients with PD who have been treated with levodopa for long time. We focus on the research results and further development research directions of LID that include animal models, mechanism and treatments in this review. Key words: Parkinson’s disease; Dyskinesia; Model, animal
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
